XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Compensation Expense Information The following table provides information regarding our stock-based compensation:
Three Months Ended December 31, Nine Months Ended December 31,
(In thousands)2022202120222021
Pre-tax stock-based compensation costs charged against income$2,433 $2,234 $9,756 $7,331 
Income tax benefit recognized on compensation costs$49 $132 $924 $644 
Total fair value of options and RSUs vested during the period$63 $— $10,352 $7,943 
Cash received from the exercise of stock options$5,684 $3,011 $7,173 $5,718 
Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises$731 $789 $3,626 $2,860 
Summary of Restricted Shares A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:
 
 
 
RSUs
 
Shares
(in thousands)
Weighted
Average
Grant-Date
Fair Value
Nine Months Ended December 31, 2021
Unvested at March 31, 2021457.0 $33.52 
Granted170.8 45.32 
Vested (162.3)32.99 
Forfeited(24.6)30.54 
Unvested at December 31, 2021440.9 38.45 
Vested at December 31, 2021152.3 33.92 
   
Nine Months Ended December 31, 2022
Unvested at March 31, 2022440.9 $38.45 
Granted151.0 55.03 
Incremental performance shares42.4 — 
Vested (223.4)32.09 
Forfeited(1.9)49.51 
Unvested at December 31, 2022409.0 47.17 
Vested at December 31, 2022108.5 36.54 
Fair Value of Options Granted
The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:
 Nine Months Ended December 31,
 2022 2021
Expected volatility
30.8% - 30.9%
 
31.1% - 31.9%
Expected dividends$—  $— 
Expected term in years
6.0 to 7.0
 
6.0 to 7.0
Risk-free rate
2.8% to 2.9%
 
1.0% to 1.3%
Weighted average grant date fair value of options granted$20.10 $14.87 
Stock Option Activity A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:
 
 
 
 
Options
 
 
Shares
(in thousands)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Nine Months Ended December 31, 2021
Outstanding at March 31, 20211,114.9 $37.92 
Granted234.2 44.74 
Exercised(191.3)29.90 
Forfeited(13.7)37.83 
Expired(8.5)56.63 
Outstanding at December 31, 20211,135.6 40.54 6.8$22,833 
Vested at December 31, 2021656.0 40.65 5.5$13,122 
Nine Months Ended December 31, 2022    
Outstanding at March 31, 20221,100.9 $40.62 
Granted197.6 54.48 
Exercised(200.2)35.82 
Forfeited (10.3)49.53 
Expired(0.8)44.33 
Outstanding at December 31, 20221,087.2 43.94 6.7$20,289 
Vested at December 31, 2022670.5 41.18 5.4$14,360